Sarepta Therapeutics (SRPT) Other Working Capital Changes (2013 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Other Working Capital Changes of -$274.9 million for Q1 2026, down 221.93% year-over-year from $225.5 million in Q1 2025, and down 881.18% quarter-over-quarter from -$28.0 million in Q4 2025.
Sarepta Therapeutics (SRPT) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Sarepta Therapeutics' Other Working Capital Changes history runs 14 years deep, the most recent figure standing at -$274.9 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 221.93% year-over-year to -$274.9 million; the TTM figure through Mar 2026 stood at -$117.5 million (down 74.96% YoY), while the FY2025 annual figure was $72.1 million, up 324.04% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$274.9 million, down from -$28.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $122.7 million in Q2 2025, with the low at -$274.9 million in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$17.5 million (2022), against an average of -$19.2 million.
- Peak annual rise in Other Working Capital Changes reached 267.38% in 2024, while the deepest fall reached 1424.07% in 2024.
- Sarepta Therapeutics' Other Working Capital Changes stood at -$22.5 million in 2022, then soared by 79.13% to -$4.7 million in 2023, then plunged by 1424.07% to -$71.5 million in 2024, then jumped by 60.83% to -$28.0 million in 2025, then slumped by 881.18% to -$274.9 million in 2026.
- Business Quant data shows SRPT's Other Working Capital Changes at -$274.9 million in Q1 2026, -$28.0 million in Q4 2025, and $62.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.13 Mn |
| Jun 30, 2026 | -32.13 Mn |
| Jun 30, 2026 | -32.13 Mn |
| Mar 31, 2026 | -274.92 Mn |
| Mar 31, 2026 | -274.92 Mn |
| Mar 31, 2026 | -274.92 Mn |
| Dec 31, 2025 | -28.02 Mn |
| Dec 31, 2025 | -28.02 Mn |
| Dec 31, 2025 | -28.02 Mn |
| Sep 30, 2025 | 62.81 Mn |
| Sep 30, 2025 | 62.81 Mn |
| Sep 30, 2025 | 62.81 Mn |
| Jun 30, 2025 | 122.66 Mn |
| Jun 30, 2025 | 122.66 Mn |
| Jun 30, 2025 | 122.66 Mn |
| Mar 31, 2025 | -85.40 Mn |
| Mar 31, 2025 | -85.40 Mn |
| Mar 31, 2025 | -85.40 Mn |
| Dec 31, 2024 | -71.54 Mn |
| Dec 31, 2024 | -71.54 Mn |